Analysis by multiplex PCR of the physical status of human papillomavirus type 16 DNA in cervical cancers

Journal of Clinical Microbiology

Volumn 37, Issue 11, 1999, Pages 3514-3517

  Yoshinouchi, Mitsuo ^a   Hongo, Atsushi ^a   Nakamura, Keichiro ^a   Kodama, Junichi ^a   Itoh, Sachio ^a   Sakai, Hiroyuki ^b   Kudo, Takafumi ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; CANCER GROWTH; CARCINOGENESIS; GENE DISRUPTION; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SOUTHERN BLOTTING; UTERINE CERVIX CANCER; VIRUS CHARACTERIZATION; VIRUS DIAGNOSIS; VIRUS GENE; VIRUS ISOLATION; WART VIRUS;

EID: 0032833276     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.11.3514-3517.1999     Document Type: Article

References (33)

1. Bernard, B. A., C. Bailly, M.-C. Lenoir, M. Darmon, F. Thierry, and M. Yaniv. 1989. The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV 18 regulatory region in human keratinocytes. J. Virol. 63:4317-4324.
2. Bosch, F. X., M. M. Manos, N. Munoz, M. Sherman, A. M. Jansen, J. Peto, M. H. Schiffman, V. Moreno, R. Kurman, and K. V. Shah. 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. Natl. Cancer Inst. 87:796-802.
3. Boshart, M., L. Gissmann, H. Ikenberg, A. Kleinheinz, W. Scheurlen, and H. zur Hausen. 1984. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J. 3: 1151-1157.
4. Choo, K., W. Cheung, L. Liew, H. Lee, and S. Han. 1989. Presence of catenated human papillomavirus type 16 episomes in a cervical carcinoma cell line. J. Virol. 63:782-789.
5. Claas, E. C. J., W. J. G. Melchers, H. C. van der Linden, J. Lindeman, and W. G. V. Quint. 1989. Human papillomavirus detection in paraffin-embedded cervical carcinomas and metastases of the carcinomas by the polymerase chain reaction. Am. J. Pathol. 135:703-709.
6. Culleo, A. P., R. Reid, M. Campion, and A. T. Lorinez. 1991. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasms. J. Virol. 65:606-612.
7. Czeglédy, J., R. Póka, G. Veress, and L. Gergely. 1992. Amplification of human papillomavirus type 16 transforming genes from cervical cancer biopsies and lymph nodes of Hungarian patients. J. Clin. Microbiol. 30:233-236.
8. Das, B. C., J. K. Sharma, V. Gopalakrishna, and U. K. Luthra. 1992. Analysis by polymerase chain reaction of the physical state of human papillomavirus type 16 DNA in cervical preneoplastic and neoplastic lesions. J. Gen. Virol. 73:2327-2336.
9. Di Luca, D., P. Monini, A. Rotola, A. Saviolli, and E. Cassai. 1989. Episomal HPV 16 DNA isolated from a cervical carcinoma presents a partial duplication of the early region. Virus Res. 14:49-56.
10. Dowhanick, J. J., A. A. McBride, and P. M. Howley. 1995. Suppression of cellular proliferation by the papillomavirus E2 protein. J. Virol. 69:7791-7799.
11. Dürst, M., A. Kleinheinz, M. Hotz, and L. Gissman. 1985. The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumors. J. Gen. Virol. 66:1515-1522.
12. Fuchs, P. G., F. Girardi, and H. Pfister. 1989. Human papillomavirus 16 DNA in cervical cancers and in lymph nodes of cervical cancer patients: a diagnostic marker for early metastases? Int. J. Cancer 43:41-44.
13. Howley, P. M. 1985. Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am. J. Pathol. 119:361-366.
14. Hwang, E. S., D. J. Riese II, J. Settleman, L. A. Nilson, J. Honig, S. Flynn, and D. DiMaio. 1993. Inhibition of cervical carcinoma cell line proliferation by the introduction of a bovine papillomavirus regulatory gene. J. Virol. 67: 3720-3729.
15. Jeon, S., and P. F. Lambert. 1995. Integration of HPV-16 DNA into the human genome leads to increased stability of E6/E7 mRNAs: implications for cervical carcinogenesis. Proc. Natl. Acad. Sci. USA 92:1654-1658.
16. Karlsen, F., M. Kalantari, A. Jenkins, E. Pettersen, G. Kristensen, R. Holm, B. Johansson, and B. Hagmar. 1996. Use of multiple PCR primer sets for optimal detection of human papillomavirus. J. Clin. Microbiol. 34:2095-2100.
17. Kobayashi, Y., M. Yoshinouchi, G. Tianqi, K. Nakamura, A. Hongo, S. Kamimura, Y. Mizutani, J. Kodama, Y. Miyagi, and T. Kudo. 1998. Presence of human papilloma virus DNA in pelvic lymph nodes can predict unexpected recurrence of cervical cancer in patients with histologically negative lymph nodes. Clin. Cancer Res. 4:979-983.
18. Lewandowski, G., G. Delgado, R. W. Holloway, M. Farrell, B. Jenson, and W. D. Lancaster. 1990. The use of in situ hybridization to show human papillomavirus deoxyribonucleic acid in metastatic cancer cells within lymph nodes. Am. J. Obstet. Gynecol. 163:1333-1337.
19. Park, J. S., E. S. Hwang, S. N. Park, H. K. Ahn, S. J. Um, C. J. Kim, and S. J. Kim. 1997. Physical status and expression of HPV genes in cervical cancers. Gynecol. Oncol. 65:121-129.
20. Pattilo, R. A., R. O. Hussa, M. T. Story, A. C. F. Ruckert, M. R. Shalaby, and R. F. Mattingly. 1977. Tumor antigen and human chorionic gonadotropin in CaSki cells: a new epidermoid cervical cancer cell line. Science 196:1456-1458.
21. Romanczuk, H., F. Thierry, and P. M. Howley. 1990. Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters. J. Virol. 64:2849-2859.
22. Seedorf, K., G. Krämmer, M. Dürst, S. Suhai, and W. G. Röwekamp. 1985. Human papillomavirus-type-16 DNA sequence. Virology 145:181-185.
23. Seki, A., J. Kodama, Y. Miyagi, S. Kamimura, M. Yoshinouchi, and T. Kudo. 1997. Amplification of the mdm-2 gene and P53 abnormalities in uterine sarcomas. Int. J. Cancer. 73:33-37.
24. Seki, A., K. Nakamura, J. Kodama, Y. Miyagi, M. Yoshinouchi, and T. Kudo. 1998. A close correlation between c-erbB-2 gene amplification and local progression in endometrial adenocarcinoma. Eur. J. Gynaecol. Oncol. 19: 90-92.
25. Southern, E. M. 1975. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98:503-517.
26. Thierry, F., and P. M. Howley. 1991. Functional analysis of E2 mediated repression of the HPV 18 P105 promotor. New Biol. 3:90-100.
27. Tsunokawa, Y., N. Takebe, S. Nozawa, T. Kasamatsu, L. Gissmann, H. zur Hausen, M. Terada, and T. Sugimura. 1986. Presence of human papillomavirus type-16 and type-18 DNA sequences and their expression in cervical cancers and cell lines from Japanese patients. Int. J. Cancer 37:499-503.
28. Vernon, S. D., E. R. Unger, D. L. Miller, D. R. Lee, and W. C. Reeves. 1997. Association of human papillomavirus type 16 integration in the E2 gene with poor disease-free survival from cervical cancer. Int. J. Cancer 74:50-56.
29. Vousden, K. 1993. Interactions of human papillomavirus transforming proteins with the products of tumor suppressor genes. FASEB J. 7:872-879.
30. Walboomers, J. M., and C. J. Meijer. 1997. Do HPV-negative cervical carcinomas exist? J. Pathol. 181:253-254.
31. Walboomers, J. M. M., H. E. Fokke, M. Polak, H. Volkers, H. J. Houthoff, J. Barents, J. van der Noordaa, and J. ter Schegget. 1987. In situ localization of human papilloma virus type 16 DNA in a metastasis of an endocervical adenocarcinoma. Intervirology 27:81-85.
32. Yee, C., I. Krishnan-Hewlett, C. C. Baker, R. Schlegel, and P. M. Howley. 1985. Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am. J. Pathol. 119:361-366.
33. zur Hausen, H. 1996. Papillomavirus infections - a major cause of human cancers. Biochim. Biophys. Acta 1288:55-78.